Based on our innovative and patented technology, we are changing the early diagnosis in the areas of heart attack, stroke and severe pregnancy complications (preeclampsia) decisively. Early, effective, and faster diagnosis save patient lives through early treatment options. The current goal is to jointly expand with strategic partners and qualified investors internationally. This is crucial to carry out the necessary FDA approval and achieve the sale of the product lines and entry into the guidelines. The sales trends are already clearly visible and sustainably strengthened and accelerated by the implementation of the current capital measures. Patented technologies, exclusive unique features, and innovative products feature the fundamental strengths of our company and give our investors the security to be able to achieve capital appreciation. Walk the way with us and opt for an investment with heart.




Leading covered by a patent technologies and products



Enormous growth opportunities in the Healthcare market



Exclusive participation possibilities for certified investors



Exit strategy by IPO












Request now for further
information with the help
of of our contact form.


Or contact us
by telephone under:

+352 81 26 18 52





Contact Form